FDA Warning Letter — Pinnacle Transplant Technologies, LLC

Case 646783 — FEI 3008927553

The FDA took a Warning Letter action against Pinnacle Transplant Technologies, LLC on Oct 1, 2024 (Phoenix, AZ). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Pinnacle Transplant Technologies, LLC
Date
Oct 1, 2024
Fiscal Year
2025
Product Type
Biologics
Center
CBER
Location
Phoenix, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.